Safety and Efficacy Study of IPG Patient With Home Monitoring

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1327 participants.

Also called NCT01523704

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,327 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01523704
Other papers using this trial's data
  • Remote Management of Pacemaker Patients With Biennial In-Clinic Evaluation: Continuous Home Monitoring in the Japanese At-Home Study: A Randomized Clinical Trial Circulation. Arrhythmia and electrophysiology, 2020-05 DOI, PubMed 32342703, PMC7237026 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01523704. Randomized; no masking; primary purpose treatment. Start 2012-01 (actual); primary completion 2016-02 (actual). Results posted on 2021-01-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of IPG Patient With Home Monitoring
Condition
Bradyarrhythmia
Intervention (Device)
BIOTRONIK Home Monitoring System
Intervention (Device)
BIOTRONIK Home Monitoring System with In-office Follow-up
Lead sponsor
Biotronik Japan, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01523704
Content hash
2589cda6d89cac3b6611cc35bc87a0ed74727817fd4f17583499ee143c1ffafe